Versie door Update bot(overleg | bijdragen) op 26 jun 2024 om 17:04 (Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.11.1(EN)|1|Vaccination-v6.0.1(2024EN)}} <!-- Tot hier de transclude page --> ==General information<!--hdGeneralInformation-->== Name<!--hdName-->: '''nl.zorg.Vaccination''' link=Vaccinatie-v6.0.1(2024NL)<BR> Version<!--hdVersion-->: '''6.0.1''' <br> HCIM Status<!--hdStatus-->:Final<br> Release<!--hdPublication-->: '''2024''' <br> Re...')
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet Voorschrijfcode (PRK) van concept ProductCode aangepast naar tagged value DCM::CodeSystem G-Standaard Voorschrijfproducten (PRK).
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet KNMP artikelnummer = ATKODE van concept ProductCode aangepast naar tagged value DCM::CodeSystem G-Standaard Artikelen (Bestand 004). KNMP artikelnummer = ATKODE in tagged value notes geplaatst.
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet Handelsproductcode (HPK) van concept ProductCode aangepast naar tagged value DCM::CodeSystem G-Standaard HPK (Handels Product Kode).
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet GTIN International Article Number van concept ProductCode aangepast naar tagged value DCM::CodeSystem GTIN (Global Trade Item Number). OID 2.16.528.1.1002 aangepast in 1.3.160.
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet ATC (Anatomic Therapeutic Classification) van concept ProductCode aangepast naar tagged value DCM::CodeSystem ATC (Anatomic Therapeutic Classification).
In de klinische bouwsteen OverdrachtVaccinatie DCM::ValueSet Generieke productcode (GPK) van concept ProductCode aangepast naar tagged value DCM::CodeSystem G-Standaard GPK (Generieke Product Kode).
2023-1 Verwijzingen naar FarmaceutischProduct gebruiken verkeerde NL-CM id
Concept
Immunisation can be defined as "The generation of natural immunity against pathogens by vaccination (active immunisation) or by administration of immunoglobulins (passive immunisation)".
Only vaccinations (administered and scheduled) are included in this building block. The administration of immunoglobulins is part of the medication overview. Vaccinations have lifelong relevance.
Most vaccinations are carried out in the Netherlands as part of the National Vaccination Programme (RVP).
Vaccinations are also relevant in adult patients such as transplant patients, dialysis patients and patients with status after spleen aspiration. In addition, there are specific indications for vaccination of high-risk groups, such as travellers, professionals who come into contact with blood or patients with injuries, impaired immunity or increased risk.
Purpose
Documenting vaccinations that have already taken place in a patient or are planned is important for things such as the diagnostics of infectious diseases and the indication and planning of (re)vaccinations.
Information Model
Type
Id
Concept
Card.
Definition
DefinitionCode
Reference
NL-CM:11.1.1
Vaccination
Root concept of the Vaccination information model. This root concept contains all data elements of the Vaccination information model.
NL-CM:11.1.3
VaccinationDateTime
1
Date (and if possible time) that the vaccine is administered. In the case of a historical vaccination, a vague date (month, year) is allowed.
NL-CM:11.1.8
Location::HealthcareProvider
1
The healthcare provider where the vaccination is or will be carried out.
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR